Coherus Oncology, Inc.: cash_and_restricted_cash
| Value | {"amount": 159071000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2015-12-31) |
| Status | current |
| Entity | Coherus Oncology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:10:52.643173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/05b7ed63-8c7f-43c9-8775-6439f192a82d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-005470Retrieved: 2026-08-19T15:10:52.643173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001512762/cash-and-restricted-cash/2015-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/05b7ed63-8c7f-43c9-8775-6439f192a82d
History
- no predecessors — first report